Speakers
Eva-Lotta Allan, Independent Non-Executive Director
Kate Bingham, Managing Partner, SV Health Investors
Jens Eckstein, Managing Partner, Apollo Health Ventures
Bill Enright, CEO, Vaccitech
Tim Haines, Chairman & Managing Partner, Abingworth
Peter Hamley, CSO, Samsara Therapeutics
Daniel Ives, CEO, Shift Bioscience
Peter Joyce, CEO, Co-Founder, Grey Wolf Therapeutics
Jason Mellad, CEO Start Codon
Melanie Lee, CEO, LifeArc
Müge Ogrunc, CSO, StarkLabs
Heather Fairhead, CEO, Phico Therapeutics
James Field, Founder and CEO, LabGenius
Emma Tinsley, CEO, Weatherden
John Harris, CEO, OBN
Karen Miller, Senior Vice President, Pipeline Research, Adaptimmune
Geert-Jan Mulder, Managing Partner, Forbion
Ian Nicholson, CEO, F2G
Cheerag Shirodaria, Founder & CEO, Caristo Diagnostics
Mark Stevenson, Executive Vice President and Chief Operating Officer, Thermo Fisher
Neil Thompson, CSO, Healx
James Tumbridge, Partner, Venner Shipley
Tim Wilson, CEO, Epsilogen
Gary Woodward, CTO, Ultromics
Gonzalo Garcia, Chief of Staff, Resolution Therapeutics
Olivia Rossanese, Director, Cancer Therapeutics Unit, ICR
Kath Mackay, Managing Director, Alderley Park
Barbara Domanyne-Hayman, Entrepreneur in Residence, The Francis Crick Institute
Katie Binley, CSO, Ikarovec
June Raine, Chief Executive, MHRA
Processing. Please wait.
Loading...